Difference between revisions of "Ding Kai"
From Bioblast
| Line 2: | Line 2: | ||
|lastname=Ding | |lastname=Ding | ||
|firstname=Kai | |firstname=Kai | ||
| | |institution=Department of Pharmaceutical Sciences/BRITE | ||
North Carolina Central University | North Carolina Central University | ||
|address=302 E. Lawson Street | |||
BRITE Building, Room 2025 | |||
Durham | |area code=27707 | ||
|city=Durham | |||
|state=North Carolina (NC) | |||
|country=USA | |||
}} | }} | ||
{{Labelingperson}} | |||
Revision as of 11:33, 9 October 2014
| Name | Ding Kai, |
|---|---|
| Institution | Department of Pharmaceutical Sciences/BRITE
North Carolina Central University |
| Address | 302 E. Lawson Street
BRITE Building, Room 2025, 27707 |
| City | Durham |
| State/Province | North Carolina (NC) |
| Country | USA |
| Weblink | |
| O2k-Network Lab | US NC Durham Li PA |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Lu 2018 ACS Infect Dis | 2018 | Lu X, Williams Z, Hards K, Tang J, Cheung CY, Aung HL, Wang B, Liu Z, Hu X, Lenaerts AJ, Woolhiser L, Hastings C, Zhang X, Wang Z, Rhee KY, Ding K, Zhang T, Cook GM (2018) A pyrazolo[1,5-a]pyridine inhibitor of the respiratory cytochrome bcc complex for the treatment of drug-resistant tuberculosis. ACS Infect Dis 5:239-49. |
